Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19

12 Nov 2020

Abstract excerpt

No definitive treatment for COVID-19 exists although promising results have been reported with remdesivir and glucocorticoids. Short of a truly effective preventive or curative vaccine against SARS-CoV-2, it is becoming increasingly clear that multiple pathophysiologic processes seen with COVID-19 as well as SARS-CoV-2 itself should be targeted. Because alpha-1-antitrypsin (AAT) embraces a panoply of biologic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Mosquito-borne diseases and control
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33239231
DOI: 10.1016/j.mehy.2020.110394

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19PMID 33239231Read ↗

Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidenceSemantic proximity Read ↗

Therapeutic application of alpha-1-antitrypsin in COVID-19Semantic proximity Read ↗

Potential COVID‐19 therapeutic approaches targeting angiotensin‐converting enzyme 2; An updated reviewSemantic proximity Read ↗

SARS‐CoV ‐2 multifaceted interaction with the human host. Part II : Innate immunity response, immunopathology, and epigeneticsSemantic proximity Read ↗

Proteome reveals antiviral host response and NETosis during acute COVID-19 in high-risk patientsSemantic proximity Read ↗

Molecular mechanisms of Thalidomide effectiveness on COVID-19 patients explained: ACE2 is a new ΔNp63α target geneSemantic proximity Read ↗

A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application.Semantic proximity Read ↗

Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry PerspectiveSemantic proximity Read ↗

PAD Inhibitors as a Potential Treatment for SARS-CoV-2 ImmunothrombosisSemantic proximity Read ↗

Combating COVID-19 with mesenchymal stem cell therapySemantic proximity Read ↗

COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbiditySemantic proximity Read ↗

Modulation of Autophagy by SARS-CoV-2: A Potential Threat for Cardiovascular SystemSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.